Clinical Trial Collaborations, April 9-11, 2018, Boston Marriott Cambridge, Cambridge, MA, USA

Overview

The Clinical Trial Collaborations (CTC) conference is a strategic level event focusing on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes.

We are pleased to announce that the 3rd annual conference is co-chaired by Ken Getz, Director of Sponsored Research Programs, Tufts CSDD and Murray Abramson, MD, VP Global Clinical Operations, Biogen. Ken also gives the state of the industry address on Mapping the Evolution of Contract Clinical Collaborations to help prepare operation professionals with an understanding of the latest data on:

1. The strategic implications of an unprecedented level of acquisitions dominated by private equity investment
2. The current structure and concentration of the CRO marketplace
3. What to think about and how to prepare for the changing clinical outsourcing landscape

– CTC is Divided into Three Sections –

1. Clinical Collaborations: The Evolution, Current Examples to Challenge Us & Progress
2. Strategic Collaborations, Virtual Trials & Next Generation Monitoring
3. Clinical Research as a Care Option & How to Collaborate to Achieve This